1.8.6Segment

Healthcare & Life Sciences Research

Research organizations delivering health economics, outcomes research, and market intelligence for pharmaceutical and healthcare clients.

4
Verticals

Overview

Healthcare & Life Sciences Research firms deliver health economics and outcomes research (HEOR), real-world evidence, and market intelligence for pharmaceutical, biotech, and healthcare clients. It is a specialized, methods-driven research market that supports drug commercialization, payer access, and healthcare strategy — distinct from the laboratory R&D it is sometimes conflated with.

Demand is driven by drug pipelines, payer evidence requirements, and the data needs of pharma commercialization, with major consolidation around real-world-data and analytics platforms (IQVIA and peers). It is a growing, data-asset-driven niche.

Market snapshot

FragmentationConsolidating

No clean Census NAICS code — the mapped R&D codes (541713/541715, ~$240B) measure in-house physical/engineering/life-sciences laboratory R&D, a different activity; HEOR and market-intelligence services are not separately sized.

Business model & economics

Revenue model
Project research plus recurring real-world-data and analytics subscriptions
Recurring revenue
Moderate–High — real-world-data platforms recur
EBITDA margin
18–30%
Capex intensity
Low
  • Methods- and data-driven research, not laboratory R&D.
  • Drug pipelines and payer evidence needs drive demand.
  • Real-world-data platforms carry the recurring, high-value revenue.

M&A deal context

Moderate deal activity

Who’s acquiring

Real-world-data & analytics platformsPharma-services consolidatorsPE-backed healthcare-research roll-ups

What’s driving deals

  • Consolidation around real-world-data and analytics platforms.
  • Pharma commercialization and payer-evidence demand.
  • Recurring health-data assets attracting buyers.

Verticals in this segment

  • 1.8.6.1Health Economics & Outcomes Research

    Research organizations studying healthcare intervention cost-effectiveness.

  • 1.8.6.2Healthcare Market Research

    Research firms studying provider and patient behaviors in healthcare.

  • 1.8.6.3Pharmacoeconomics & HEOR

    Consultancies modeling drug value and health economics.

  • 1.8.6.4Real-World Evidence Research

    Organizations analyzing real-world patient data and treatment outcomes.

Find Healthcare & Life Sciences Research acquisition targets

Search Acquisera’s index for companies classified under Healthcare & Life Sciences Research (1.8.6) and build a targeted deal pipeline.

Search companies